Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study on pistachio shell filled PLA composites for FDM-based processing.

Scientific reports·2025
Same author

Wettability-Driven void suppression and enhanced mechanical performance in Si₃N₄-Reinforced bamboo Fiber epoxy composites using COCOSO and ANN modeling.

Scientific reports·2025
Same author

Effect of nozzle temperature and infill patterns on enhancing crashworthiness performance of 3D printed glass fibre reinforced PLA parts.

Scientific reports·2025
Same author

Enhancing drilling performance in 3D printed PLA implants application of PIV and ML models.

Scientific reports·2025
Same author

Additive manufacturing for biomedical applications: a review on classification, energy consumption, and its appreciable role since COVID-19 pandemic.

Progress in additive manufacturing·2024
Same author

Erratum: Publisher Correction: Additive manufacturing for biomedical applications: a review on classification, energy consumption, and its appreciable role since COVID-19 pandemic.

Progress in additive manufacturing·2024

Related Experiment Video

Updated: Jul 16, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Impurity profile study of zaleplon.

Ch Bharathi1, K Joseph Prabahar, Ch S Prasad

  • 1A.P.L. Research Centre, 313 Bachupally, Hyderabad 500072, India.

Journal of Pharmaceutical and Biomedical Analysis
|March 21, 2007
PubMed
Summary

Seven unknown impurities in zaleplon bulk drug were identified and characterized using advanced analytical techniques. This study details their structures and formation pathways, crucial for pharmaceutical quality control.

More Related Videos

Qualitative Characterization of the Aqueous Fraction from Hydrothermal Liquefaction of Algae Using 2D Gas Chromatography with Time-of-flight Mass Spectrometry
11:44

Qualitative Characterization of the Aqueous Fraction from Hydrothermal Liquefaction of Algae Using 2D Gas Chromatography with Time-of-flight Mass Spectrometry

Published on: March 6, 2016

Related Experiment Videos

Last Updated: Jul 16, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Qualitative Characterization of the Aqueous Fraction from Hydrothermal Liquefaction of Algae Using 2D Gas Chromatography with Time-of-flight Mass Spectrometry
11:44

Qualitative Characterization of the Aqueous Fraction from Hydrothermal Liquefaction of Algae Using 2D Gas Chromatography with Time-of-flight Mass Spectrometry

Published on: March 6, 2016

Area of Science:

  • Pharmaceutical Chemistry
  • Analytical Chemistry
  • Organic Chemistry

Background:

  • Zaleplon, a pyrazolopyrimidine derivative, is widely used for its sedative and hypnotic properties.
  • Ensuring the purity of bulk pharmaceutical ingredients is critical for drug safety and efficacy.
  • Previous analytical methods may not have been sufficient to detect or characterize low-level impurities in zaleplon.

Purpose of the Study:

  • To detect, isolate, and structurally elucidate unknown impurities present in zaleplon bulk drug.
  • To identify the starting materials and intermediates contributing to impurity formation.
  • To provide a comprehensive understanding of the impurity profile of zaleplon.

Main Methods:

  • Reverse-phase high-performance liquid chromatography (HPLC) for impurity detection and isolation.
  • Liquid chromatography-mass spectrometry (LC-MS) for molecular weight determination.
  • Nuclear magnetic resonance (NMR) spectroscopy (1H and 13C), mass spectrometry (MS), and infrared (IR) spectroscopy for structural characterization.

Main Results:

  • Seven unknown impurities in zaleplon bulk drug were detected at levels below 0.1%.
  • The starting material (3-amino-4-cyanopyrazole) and an intermediate (DOPEA) were also identified below 0.1%.
  • The structures of the seven impurities were fully characterized using comprehensive spectral data, with detailed assignments provided.

Conclusions:

  • The study successfully identified and characterized seven novel impurities in zaleplon, along with residual starting materials and intermediates.
  • Understanding the structural nature and formation pathways of these impurities is essential for developing robust manufacturing processes and ensuring zaleplon quality.
  • The detailed analytical characterization provides a foundation for future regulatory submissions and quality control strategies for zaleplon products.